Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 16 03 2022
accepted: 25 05 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 7 7 2022
Statut: epublish

Résumé

Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified

Identifiants

pubmed: 35784294
doi: 10.3389/fimmu.2022.897975
pmc: PMC9247144
doi:

Substances chimiques

NF-kappa B p50 Subunit 0
NFKB1 protein, human 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

897975

Informations de copyright

Copyright © 2022 Franco-Jarava, Valenzuela, Riviere, Garcia-Prat, Martínez-Gallo, Dieli-Crimi, Castells, Batlle-Masó, Soler-Palacin and Colobran.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell Res. 2011 Feb;21(2):223-44
pubmed: 21243012
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Clin Genet. 2002 Mar;61(3):226-8
pubmed: 12000367
J Med Genet. 2016 Sep;53(9):575-90
pubmed: 27250108
J Med Genet. 2006 Nov;43(11):843-9
pubmed: 16840569
Am J Med Genet A. 2009 Aug;149A(8):1830-3
pubmed: 19610119
Front Immunol. 2021 Dec 22;12:773853
pubmed: 35003091
Am J Hum Genet. 2006 Sep;79(3):500-13
pubmed: 16909388
Front Pediatr. 2020 Feb 27;8:73
pubmed: 32175298
Blood. 2020 Aug 27;136(9):1055-1066
pubmed: 32518946
J Allergy Clin Immunol. 2020 Oct;146(4):901-911
pubmed: 32278790
J Allergy Clin Immunol. 2021 Aug;148(2):523-532.e8
pubmed: 33862010
Am J Hum Genet. 2015 Sep 3;97(3):389-403
pubmed: 26279205
Genet Med. 2017 Feb;19(2):209-214
pubmed: 27441994
Clin Immunol. 2018 Oct;195:49-58
pubmed: 30063981
Am J Med Genet A. 2017 Sep;173(9):2366-2372
pubmed: 28627729
Clin Immunol. 1999 Jul;92(1):34-48
pubmed: 10413651
Eur J Pediatr. 2022 Apr;181(4):1371-1383
pubmed: 34939152
Front Immunol. 2018 May 14;9:636
pubmed: 29867916
Horm Res Paediatr. 2020;93(7-8):415-422
pubmed: 33503638
J Allergy Clin Immunol. 2018 Oct;142(4):1285-1296
pubmed: 29477724
J Exp Med. 2021 Nov 1;218(11):
pubmed: 34473196
Am J Med Genet. 2001 Oct 1;103(2):176-80
pubmed: 11568928
Mol Genet Genomic Med. 2020 Nov;8(11):e1508
pubmed: 32969205
Clin Immunol. 2018 Jun;191:44-51
pubmed: 29572183
J Clin Immunol. 2021 Apr;41(3):666-679
pubmed: 33598806
Orphanet J Rare Dis. 2016 Aug 02;11(1):110
pubmed: 27484815

Auteurs

Clara Franco-Jarava (C)

Immunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Translational Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.

Irene Valenzuela (I)

Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
Medicine Genetics Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.

Jacques G Riviere (JG)

Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Barcelona, Spain.

Marina Garcia-Prat (M)

Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Barcelona, Spain.

Mónica Martínez-Gallo (M)

Immunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Translational Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.

Romina Dieli-Crimi (R)

Immunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Translational Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.

Neus Castells (N)

Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
Medicine Genetics Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.

Laura Batlle-Masó (L)

Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.

Pere Soler-Palacin (P)

Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Barcelona, Spain.

Roger Colobran (R)

Immunology Division, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Translational Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH